ArticlePharmacology research & perspectives2020

Regulatory post-market drug safety advisories on cardiac harm: A comparison of four national regulatory agencies.

Ashleigh Hooimeyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.